TRAVIS FROGLEY, FNP-C
Family Nurse Practitioner · BOISE, ID
Individual Active NPI 1518508928
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 630 | 257,417 | $11,109,416 | $4,975,517 | $3,945,273 |
| 2023 | 393 | 196,587 | $10,509,492 | $4,711,864 | $3,749,584 |
| 2022 | 145 | 94,196 | $4,197,096 | $2,386,876 | $1,899,895 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 66,990 | $11 | $8 |
| J1306 | Injection, inclisiran, 1 mg | 49,132 | $12 | $9 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 15,600 | $22 | $17 |
| J0897 | Injection, denosumab, 1 mg | 15,360 | $25 | $20 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,680 | $31 | $25 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 586 | $98 | $77 |
| 96372 | Injection of drug or substance under skin or into muscle | 552 | $11 | $9 |
| J3489 | Injection, zoledronic acid, 1 mg | 515 | $6 | $4 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 323 | $47 | $35 |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 223 | $15 | $12 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 102 | $21 | $17 |
| 96375 | Injection of additional new drug or substance into vein | 81 | $12 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 62675 | ID |
Medicare eligibility
- Part B
- No
- DME
- Yes
- Home health
- No
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Idaho
- NPI 1730311564
- NPI 1144193012
- NPI 1164166005
- NPI 1386750552
- NPI 1720739444
- NPI 1093529406
- NPI 1952066102
- NPI 1376011619
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.